Prostate Cancer

Copyright © 2011 Eugene W. Lee and William C. Huang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. I. Thompson, J. B. Thrasher, G. Aus et al., “Guideline for the management of clinically localized prostate cancer: 2007 update,” Journal of Urology, vol. 177, no. 6, pp. 2106–2131, 2007. View at Publisher · View at Google Scholar · View at Scopus
2. M. R. Cooperberg, D. P. Lubeck, M. V. Meng, S. S. Mehta, and P. R. Carroll, “The changing face of low-risk prostate cancer: trends in clinical presentation and primary management,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2141–2149, 2004. View at Publisher · View at Google Scholar · View at Scopus
3. P. Mufarrij, A. Sankin, G. Godoy, and H. Lepor, “Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy,” Urology, vol. 76, no. 3, pp. 689–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
4. J. G. Baust and A. A. Gage, “The molecular basis of cryosurgery,” British Journal of Urology International, vol. 95, no. 9, pp. 1187–1191, 2005. View at Publisher · View at Google Scholar · View at Scopus
5. R. J. Babaian, B. Donnelly, D. Bahn et al., “Best practice statement on cryosurgery for the treatment of localized prostate cancer,” Journal of Urology, vol. 180, no. 5, pp. 1993–2004, 2008. View at Publisher · View at Google Scholar · View at Scopus
6. Millenium Research Group, US Markets for Urological Devices 2006, Millenium Research Group, Inc., Toronto, Ontario, Canada, 2005.
7. I. S. Cooper and A. S. Lee, “Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues,” The Journal of Nervous and Mental Disease, vol. 133, pp. 259–263, 1961. View at Google Scholar · View at Scopus
8. M. J. Gonder, W. A. Soanes, and S. Shulman, “Cryosurgical treatment of the prostate,” Investigative urology, vol. 3, no. 4, pp. 372–378, 1966. View at Google Scholar · View at Scopus
9. R. H. Flocks, C. M. Nelson, and D. L. Boatman, “Perineal cryosurgery for prostatic carcinoma,” Journal of Urology, vol. 108, no. 6, pp. 933–935, 1972. View at Google Scholar · View at Scopus
10. G. M. Onik, J. K. Cohen, G. D. Reyes, B. Rubinsky, Z. Chang, and J. Baust, “Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate,” Cancer, vol. 72, no. 4, pp. 1291–1299, 1993. View at Google Scholar · View at Scopus
11. J. K. Cohen, R. J. Miller, and B. A. Shuman, “Urethral warming catheter for use during cryoablation of the prostate,” Urology, vol. 45, no. 5, pp. 861–864, 1995. View at Publisher · View at Google Scholar · View at Scopus
12. A. Zisman, A. J. Pantuck, J. K. Cohen, and A. S. Belldegrun, “Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template—technique and preliminary results,” Urology, vol. 58, no. 6, pp. 988–993, 2001. View at Publisher · View at Google Scholar · View at Scopus
13. D. S. Ellis, “Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience,” Urology, vol. 60, no. 2, pp. 34–39, 2002. View at Publisher · View at Google Scholar · View at Scopus
14. D. A. Levy, L. L. Pisters, and J. S. Jones, “Primary cryoablation nadir prostate specific antigen and biochemical failure,” Journal of Urology, vol. 182, no. 3, pp. 931–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
15. D. K. Bahn, F. Lee, R. Badalament, A. Kumar, J. Greski, and M. Chernick, “Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer,” Urology, vol. 60, no. 2, pp. 3–11, 2002. View at Publisher · View at Google Scholar · View at Scopus
16. J. P. Long, D. Bahn, F. Lee, K. Shinohara, D. O. Chinn, and J. N. Macaluso, “Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate,” Urology, vol. 57, no. 3, pp. 518–523, 2001. View at Publisher · View at Google Scholar · View at Scopus
17. J. K. Cohen, R. J. Miller Jr., S. Ahmed, M. J. Lotz, and J. Baust, “Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy,” Urology, vol. 71, no. 3, pp. 515–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
18. D. S. Ellis, T. B. Manny Jr., and J. C. Rewcastle, “Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation,” Urology, vol. 69, no. 2, pp. 306–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
19. M. Roach, G. Hanks, H. Thames Jr. et al., “Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 4, pp. 965–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
20. M. S. Cookson, G. Aus, A. L. Burnett et al., “Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes,” Journal of Urology, vol. 177, no. 2, pp. 540–545, 2007. View at Publisher · View at Google Scholar · View at Scopus
21. J. S. Jones, J. C. Rewcastle, B. J. Donnelly, F. M. Lugnani, L. L. Pisters, and A. E. Katz, “Whole gland primary prostate cryoablation: initial results from the cryo in-line data registry,” Journal of Urology, vol. 180, no. 2, pp. 554–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
22. K. Shinohara, B. Rhee, J. C. Presti Jr., and P. R. Carroll, “Cryosurgical ablation of prostate cancer: patterns of cancer recurrence,” Journal of Urology, vol. 158, no. 6, pp. 2206–2210, 1997. View at Publisher · View at Google Scholar · View at Scopus
23. R. M. Benoit, J. K. Cohen, and R. J. Miller, “Cryosurgery for prostate cancer: new technology and indications,” Current Urology Reports, vol. 1, no. 1, pp. 41–47, 2000. View at Google Scholar · View at Scopus
24. B. J. Donnelly, J. C. Saliken, D. S. Ernst et al., “Prospective trial of cryosurgical ablation of the prostate: five-year results,” Urology, vol. 60, no. 4, pp. 645–649, 2002. View at Publisher · View at Google Scholar · View at Scopus
25. B. J. Donnelly, J. C. Saliken, P. M. A. Brasher et al., “A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer,” Cancer, vol. 116, no. 2, pp. 323–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
26. J. Crook, S. Malone, G. Perry, Y. Bahadur, S. Robertson, and M. Abdolell, “Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients,” International Journal of Radiation Oncology Biology Physics, vol. 48, no. 2, pp. 355–367, 2000. View at Publisher · View at Google Scholar · View at Scopus
27. K. L. Prepelica, Z. Okeke, A. Murphy, and A. E. Katz, “Cryosurgical ablation of the prostate: high-risk patient outcomes,” Cancer, vol. 103, no. 8, pp. 1625–1630, 2005. View at Publisher · View at Google Scholar · View at Scopus
28. J. P. Long, M. L. Fallick, D. R. LaRock, and W. Rand, “Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma,” Journal of Urology, vol. 159, no. 2, pp. 477–484, 1998. View at Publisher · View at Google Scholar · View at Scopus
29. K. R. Han, J. K. Cohen, R. J. Miller et al., “Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience,” Journal of Urology, vol. 170, no. 4 I, pp. 1126–1130, 2003. View at Publisher · View at Google Scholar · View at Scopus
30. S. G. Hubosky, M. D. Fabrizio, P. F. Schellhammer, B. B. Barone, C. M. Tepera, and R. W. Given, “Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life,” Journal of Endourology, vol. 21, no. 12, pp. 1521–1531, 2007. View at Publisher · View at Google Scholar · View at Scopus
31. T. J. Polascik, I. Nosnik, J. M. Mayes, and V. Mouraviev, “Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology,” Urology, vol. 70, no. 1, pp. 117–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
32. N. Dhar, M. Cher, Z. Liss, D. Levy, A. Katz, and J. S. Jones, “Primary full gland and salvage prostate cryoablation: updated results from 4693 patients tracked with the cold registry,” The Journal of Urology, vol. 183, article no. e184, 2010. View at Google Scholar
33. G. Onik, D. Vaughan, R. Lotenfoe, M. Dineen, and J. Brady, ““Male Lumpectomy”: focal therapy for prostate cancer using cryoablation,” Urology, vol. 70, supplement 6, pp. S16–S21, 2007. View at Publisher · View at Google Scholar · View at Scopus
34. D. K. Bahn, P. Silverman, F. Lee, R. Badalament, E. D. Bahn, and J. C. Rewcastle, “Focal prostate cryoablation: initial results show cancer control and potency preservation,” Journal of Endourology, vol. 20, no. 9, pp. 688–692, 2006. View at Publisher · View at Google Scholar · View at Scopus
35. E. H. Lambert, K. Bolte, P. Masson, and A. E. Katz, “Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer,” Urology, vol. 69, no. 6, pp. 1117–1120, 2007. View at Publisher · View at Google Scholar · View at Scopus
36. D. S. Ellis, T. B. Manny Jr., and J. C. Rewcastle, “Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results,” Urology, vol. 70, supplement 6, pp. S9–S15, 2007. View at Publisher · View at Google Scholar · View at Scopus
37. S. Madersbacher, M. Pedevilla, L. Vingers, M. Susani, and M. Marberger, “Effect of high-intensity focused ultrasound on human prostate cancer in vivo,” Cancer Research, vol. 55, no. 15, pp. 3346–3351, 1995. View at Google Scholar · View at Scopus
38. G. Ter Haar and C. Coussios, “High intensity focused ultrasound: physical principles and devices,” International Journal of Hyperthermia, vol. 23, no. 2, pp. 89–104, 2007. View at Publisher · View at Google Scholar · View at Scopus
39. S. Madersbacher, C. Kratzik, M. Susani et al., “Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound,” Journal of Urology, vol. 152, no. 6, pp. 1956–1961, 1994. View at Google Scholar · View at Scopus
40. A. Gelet, J. Y. Chapelon, R. Bouvier et al., “Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience,” European Urology, vol. 29, no. 2, pp. 174–183, 1996. View at Google Scholar · View at Scopus
41. A. Blana, B. Walter, S. Rogenhofer, and W. F. Wieland, “High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience,” Urology, vol. 63, no. 2, pp. 297–300, 2004. View at Publisher · View at Google Scholar · View at Scopus
42. T. Uchida, H. Ohkusa, Y. Nagata, T. Hyodo, T. Satoh, and A. Irie, “Treatment of localized prostate cancer using high-intensity focused ultrasound,” British Journal of Urology International, vol. 97, no. 1, pp. 56–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
43. H. U. Ahmed, E. Zacharakis, T. Dudderidge et al., “High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series,” British Journal of Cancer, vol. 101, no. 1, pp. 19–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
44. L. Mearini, L. D'Urso, D. Collura et al., “Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience,” Journal of Urology, vol. 181, no. 1, pp. 105–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
45. A. Blana, S. Rogenhofer, R. Ganzer et al., “Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer,” Urology, vol. 72, no. 6, pp. 1329–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
46. T. Uchida, S. Shoji, M. Nakano et al., “Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience:,” International Journal of Urology, vol. 16, no. 11, pp. 881–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
47. A. Blana, S. C. W. Brown, C. Chaussy et al., “High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure,” British Journal of Urology International, vol. 104, no. 8, pp. 1058–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
48. R. Ganzer, S. C. W. Brown, G. N. Conti, F. J. Murat, G. Pasticier, and A. Gelet, “Corelation of different PSA-nadir cut off sand biochemical failure after high-intensity focused ultrasound (HIFU) of prostate cancer based on the Stuttgart failure criteria—analysis from the @-registry,” The Journal of Urology, vol. 183, article no. e182, 2010. View at Google Scholar
49. T. Uchida, M. Nakano, S. Shoji, Y. Nagata, Y. Usui, and T. Terachi, “Ten-year biochemical disease-free survival after high intensity focused ultrasound (HIFU) for localized prostate cancer: comparison with four different generation devices,” The Journal of Urology, vol. 183, article no. e183, 2010. View at Google Scholar
50. A. Blana, F. J. Murat, B. Walter et al., “First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer,” European Urology, vol. 53, no. 6, pp. 1194–1203, 2008. View at Publisher · View at Google Scholar · View at Scopus
51. R. O. Illing, T. A. Leslie, J. E. Kennedy, J. G. Calleary, C. W. Ogden, and M. Emberton, “Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy,” British Journal of Urology International, vol. 98, no. 6, pp. 1187–1192, 2006. View at Publisher · View at Google Scholar · View at Scopus
52. C. Chaussy and S. Thuroff, “Results and side effects of high-intensity focused ultrasound in localized prostate cancer,” Journal of Endourology, vol. 15, no. 4, pp. 437–440, 2001. View at Google Scholar · View at Scopus
53. S. Thuroff, C. Chaussy, G. Vallancien et al., “High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study,” Journal of Endourology, vol. 17, no. 8, pp. 673–677, 2003. View at Google Scholar · View at Scopus
54. L. Poissonnier, J. Y. Chapelon, O. Rouviere et al., “Control of prostate cancer by transrectal HIFU in 227 patients,” European Urology, vol. 51, no. 2, pp. 381–387, 2007. View at Publisher · View at Google Scholar · View at Scopus
55. H. M. Lee, J. H. Hong, and H. Y. Choi, “High-intensity focused ultrasound therapy for clinically localized prostate cancer,” Prostate Cancer and Prostatic Diseases, vol. 9, no. 4, pp. 439–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
56. G. Vallancien, D. Prapotnich, X. Cathelineau, H. Baumert, and F. Rozet, “Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study,” Journal of Urology, vol. 171, no. 6 I, pp. 2265–2267, 2004. View at Publisher · View at Google Scholar · View at Scopus
57. C. Chaussy and S. Thuroff, “The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection,” Current Urology Reports, vol. 4, no. 3, pp. 248–252, 2003. View at Google Scholar · View at Scopus
58. R. A. Weersink, A. Bogaards, M. Gertner et al., “Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities,” Journal of Photochemistry and Photobiology B, vol. 79, p. 211, 2005. View at Google Scholar
59. R. A. Weersink, A. Bogaards, M. Gertner et al., “Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities,” Journal of Photochemistry and Photobiology B, vol. 79, no. 3, pp. 211–222, 2005. View at Publisher · View at Google Scholar · View at Scopus
60. O. Mazor, A. Brandis, V. Plaks et al., “WST11, A novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model,” Photochemistry and Photobiology, vol. 81, no. 2, pp. 342–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
61. J. Trachtenberg, A. Bogaards, R. A. Weersink et al., “Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response,” Journal of Urology, vol. 178, no. 5, pp. 1974–1979, 2007. View at Publisher · View at Google Scholar · View at Scopus